SMTL ID : 2ipu.2 (1 other biounit)

PFA1 Fab fragment complexed with Abeta 1-8 peptide

Coordinates

PDB Format Compare

Method

X-RAY DIFFRACTION 1.65 Å

Oligo State

hetero-1-1-mer

Ligands

1 x ALA- GLU- PHE- ARG- HIS- ASP- SER: abeta 1-8 peptide(Non-covalent)

ALA-GLU-PHE-ARG-HIS-ASP-SER.1: 20 residues within 4Å: Chain A: H.31, S.32, N.33, Y.37, G.96, S.97, H.98, V.99, L.101 Chain B: W.49, H.52, W.54, W.55, D.56, D.58, S.60, R.100, H.102, T.103, D.108 21 PLIP interactions: 11 interactions with chain B, 10 interactions with chain A Hydrophobic interactions: B:W.49, B:H.52, B:W.54, B:H.102, A:Y.37, A:V.99, A:L.101, A:L.101 Hydrogen bonds: B:W.55, B:H.102, B:D.108, A:S.32, A:N.33, A:S.97, A:V.99 Salt bridges: B:D.56, B:D.58, B:H.102, A:H.31 pi-Cation interactions: B:W.54 pi-Stacking: A:Y.37

1 x ACM: ACETAMIDE(Covalent)

ACM.2: 6 residues within 4Å: Chain A: P.124, F.214, N.215, E.218, C.219 Chain B: V.137 3 PLIP interactions: 1 interactions with chain B, 2 interactions with chain A Hydrophobic interactions: B:V.137, A:P.124 Hydrogen bonds: A:N.215

3 x GOL: GLYCEROL(Non-functional Binders)

GOL.3: 9 residues within 4Å: Chain A: L.42, K.50, G.62, V.63, P.64, R.66, F.67, E.86, D.87 6 PLIP interactions: 6 interactions with chain A Hydrogen bonds: A:K.50, A:K.50, A:G.62, A:R.66, A:D.87, A:D.87 GOL.4: 3 residues within 4Å: Chain A: V.56, G.71, S.72 No protein-ligand interaction detected (PLIP) GOL.5: 1 residues within 4Å: Chain A: R.193 No protein-ligand interaction detected (PLIP)

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Gardberg, A.S. et al., Molecular basis for passive immunotherapy of Alzheimer's disease. Proc.Natl.Acad.Sci.Usa (2007)

Release Date

2007-10-09

Peptides

IgG2a Fab fragment Heavy Chain: A
IgG2a Fab fragment Light Chain Kappa: B

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
K

B
G

IgG2a Fab fragment Heavy Chain

IgG2a Fab fragment Light Chain Kappa

Related Entries With Identical Sequence